patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Therapeutics Announces Interim Results from PLX-PAD Clinical Trials

Pluristem Therapeutics Announces Interim Results from PLX-PAD Clinical Trials

posted on Jan 11, 2010 04:27PM
Share
New Message
Please login to post a reply